All treatments
Treatment
lactose monohydrate clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Efficacy and safety of riociguat (MK-4836) in incipient pulmonary vascular disease as an indicator for early pulmonary arterial hypertension Double-blind, randomized, multicenter, multinational, placebo-controlled phase IIa study
This study is testing a new medicine called riociguat for a condition where blood vessels in the lungs become narrow. Researchers want to see if the medicine can help improve blood flow and if it's safe for people with early signs of this lung condition.
For: Pulmonary vascular diseaseFrance · Germany · Austria - Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients with Dementia with Lewy Bodies (DLB)
This study is looking at a new medicine called neflamapimod for people with a type of memory problem called Dementia with Lewy Bodies (DLB). It aims to see if this medicine can help improve memory and thinking over 16 weeks.
Netherlands